ficerafusp alfa — Topline data
H2 2026
We expect to present data from these cohorts in the second half of 2026.Source filing
BCAX biotech catalysts & pipeline
BICARA THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
ficerafusp alfa — Interim data
mid-2027
On track for substantial enrollment of pivotal FORTIFI-HN01 study by year-end, enabling topline results from interim analysis in mid-2027; initiated FORTIFI-FLEX alternate dosing studySource filing